Effect Of Intravitreal Injection Of Bevacizumab-Chitosan Nanoparticles On Retina Of Diabetic Rats
Yan Lu,Nan Zhou,Xiao Huang,Jin-Wei Cheng,Feng-Qian Li,Rui-Li Wei,Ji-Ping Cai
DOI: https://doi.org/10.3980/j.issn.2222-3959.2014.01.01
IF: 1.645
2014-01-01
International Journal of Ophthalmology
Abstract:AIM: To investigate the effects of intravitreal injection of bevacizumab-chitosan nanoparticles on pathological morphology of retina and the expression of vascular endothelial growth factor (VEGF) protein and VEGF mRNA in the retina of diabetic rats.METHODS: Seventy-two 3-month aged diabetic rats were randomly divided into 3 groups, each containing 24 animals and 48 eyes. Both eyes of the rats in group A were injected into the vitreous at the pars plana with 3 mu L of physiological saline, while in groups B and C were injected with 3 mu L (75 mu g) of bevacizumab and 3 mu L of bevacizumab-chitosan nanoparticles (containing 75pg of bevacizumab), respectively. Immunohistochemistry was used to assess retinal angiogenesis, real -time PCR assay was used to analyze the expression of VEGF mRNA, and light microscopy was used to evaluate the morphology of retinal capillaries.RESULTS: Real -time PCR assay revealed that the VEGF mRNA expression in the retina before injection was similar to 1 week after injection in group A(P>0.05), while the VEGF mRNA expression before injection significantly differed from those 4 and 8 weeks after injection (P<0.05). Retinal expression of VEGF protein and VEGF mRNA was inhibited 1 week and 4 weeks after injection (P<0.05) in group B, and the expression of VEGF protein and VEGF mRNA was obviously inhibited until 8 weeks after injection (P<0.05) in group C. Using multiple comparisons among group A, group B, and group C, the VEGF expression before injection was higher than at 1, 4 and 8 weeks after injection (P<0.05). The amount of VEGF expression was higher 8 weeks after injection than 1 week or 4 weeks after injection, and also higher 1 week after injection compared with 4 weeks after injection (P<0.05). No toxic effect on SD rats was observed with bevacizumab -chitosan nanoparticles injection alone.CONCLUSION: The results offer a new approach for inhibiting angiogenesis of diabetic retinopathy and indicate that the intravitreal injection of bevacizumab inhibits VEGF expression in retina, and bevacizumab - chitosan nanoparticles have a longer duration of action.